DTI, AstraZeneca Partner to Position PH as Asia’s Next Clinical Research and Life Sciences hub
The Department of Trade and Industry (DTI) and pharmaceutical leader AstraZeneca are expanding their strategic partnership to establish the Philippines as Asia’s next clinical research center of excellence and a growing life sciences investment hub.
The initiative was highlighted during DTI Secretary Ma. Cristina Roque’s official visit to AstraZeneca’s Discovery Centre (DISC) in Cambridge, United Kingdom—the company’s global headquarters and R&D hub. During the visit, Secretary Roque met with AstraZenecaPhilippines Country President Lotis Ramin and Policy and Advocacy Lead Peter Olivar.





